MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1172/jci.insight.180750

Медицинская библиотека · JCI insight · 2024

Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases.

Anderson Erik, Powell Michael, Yang Emily, Kar Ananya, Leung Tung Ming, Sison Cristina, Steinberg Rebecca, Mims Raven, Choudhury Ananya, Espinosa Carlo, Zelmanovich Joshua, Okoye Nkemakonam C, Choi Eun Jung, Marder Galina, Narain Sonali, Gregersen Peter K, Mackay Meggan, Diamond Betty, Levy Todd, Zanos Theodoros P, Khosroshahi Arezou, Sanz Ignacio, Luning Prak Eline T, Bar-Or Amit, Merrill Joan, Arriens Cristina, Pardo Gabriel, Guthridge Joel, James Judith, Payne Aimee, Utz Paul J, Boss Jeremy M, Aranow Cynthia, Davidson Anne

СтатьяНаблюдательное исследованиеПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

Patients with autoimmune diseases are at higher risk for severe infection due to their underlying disease and immunosuppressive treatments. In this real-world observational study of 463 patients with autoimmune diseases, we examined risk factors for poor B and T cell responses to SARS-CoV-2 vaccination. We show a high frequency of inadequate anti-spike IgG responses to vaccination and boosting in the autoimmune population but minimal suppression of T cell responses. Low IgG responses in B cell-depleted patients with multiple sclerosis (MS) were associated with higher CD8 T cell responses. By contrast, patients taking mycophenolate mofetil (MMF) exhibited concordant suppression of B and T cell responses. Treatments with highest risk for low anti-spike IgG response included B cell depletion within the last year, fingolimod, and combination treatment with MMF and belimumab. Our data show that the mRNA-1273 (Moderna) vaccine is the most effective vaccine in the autoimmune population. There was minimal induction of either disease flares or autoantibodies by vaccination and no significant effect of preexisting anti-type I IFN antibodies on either vaccine response or breakthrough infections. The low frequency of breakthrough infections and lack of SARS-CoV-2-related deaths suggest that T cell immunity contributes to protection in autoimmune disease.

Для цитирования: Anderson Erik, Powell Michael, Yang Emily, Kar Ananya, Leung Tung Ming, Sison Cristina, Steinberg Rebecca, Mims Raven, Choudhury Ananya, Espinosa Carlo, Zelmanovich Joshua, Okoye Nkemakonam C, Choi Eun Jung, Marder Galina, Narain Sonali, Gregersen Peter K, Mackay Meggan, Diamond Betty, Levy Todd, Zanos Theodoros P, Khosroshahi Arezou, Sanz Ignacio, Luning Prak Eline T, Bar-Or Amit, Merrill Joan, Arriens Cristina, Pardo Gabriel, Guthridge Joel, James Judith, Payne Aimee, Utz Paul J, Boss Jeremy M, Aranow Cynthia, Davidson Anne. Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases.. JCI insight. 2024. DOI: 10.1172/jci.insight.180750.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.